Humacyte, Inc. (HUMA)
NASDAQ: HUMA · IEX Real-Time Price · USD
5.11
-0.26 (-4.84%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $608.52 million as of July 2, 2024. Its market cap has increased by 103.04% in one year.
Market Cap
608.52M
Enterprise Value
569.54M
1-Year Change
103.04%
Ranking
Category
Stock Price
$5.11
Market Cap Chart
Since September 18, 2020, Humacyte's market cap has increased from $128.60M to $608.52M, an increase of 373.19%. That is a compound annual growth rate of 50.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 608.50M | 106.83% |
| Dec 29, 2023 | 294.20M | 35.20% |
| Dec 30, 2022 | 217.60M | -70.86% |
| Dec 31, 2021 | 746.80M | 471.38% |
| Dec 31, 2020 | 130.70M | 1.63% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 648.40M |
| Weave Communications | 646.51M |
| Savara | 641.20M |
| Wave Life Sciences | 641.16M |
| Standard BioTools | 640.83M |
| Arcturus Therapeutics Holdings | 637.21M |
| Erasca | 634.02M |
| Definitive Healthcare | 633.31M |